TY  - JOUR
AU  - Mikkelsen, Kasper
AU  - Harwood, Seandean Lykke
AU  - Compte, Marta
AU  - Merino, Nekane
AU  - Mølgaard, Kasper
AU  - Lykkemark, Simon
AU  - Álvarez Méndez, Ana María
AU  - Blanco, Francisco J.
AU  - Álvarez Vallina, Luis
PY  - 2019
DO  - 10.3389/fimmu.2019.01791
UR  - https://hdl.handle.net/20.500.14352/108540
T2  - Frontiers in Immunology
AB  - 4-1BB (CD137) is an inducible costimulatory receptor that promotes expansion and survival of activated T cells; and IgG-based 4-1BB-agonistic monoclonal antibodies exhibited potent antitumor activity in clinical trials. However, the clinical...
LA  - eng
M2  - 1
PB  - Frontiers Media
KW  - cancer immunotherapy
KW  - immunostimulatory antibodies
KW  - costimulation
KW  - 4-1BB
KW  - 4-1BB agonists
KW  - trimerbodies
KW  - CEA
KW  - CEA-targeted 4-1BB agonists
TI  - Carcinoembryonic Antigen (CEA)-Specific 4-1BB-Costimulation Induced by CEA-Targeted 4-1BB-Agonistic Trimerbodies
TY  - journal article
VL  - 10
ER  -